from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1282c/oppC

LFCtreatmentdescriptionclass of inhibitor

-0.597

Amikacinug/mL Amikacintranslation

-0.662

Cap5-10ug/mL Capreomycintranslation

-0.931

Rox10-50 ug/mL Roxithromycintranslation

-0.058

SM2-5 ug/mL Streptomycintranslation

-3.100

Tet5-10 ug/mL Tetracyclinetranslation

-0.581

Rif0.2-5ug/mL Rifampicintranscription

-0.459

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.122

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.038

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.018

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.374

Clofazimine10-13 ug/mL Clofaziminerespiration

0.825

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.654

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.107

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.095

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.659

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.116

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.374

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.173

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.227

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.402

KCN5-20 ug/mL Potassium cyaniderespiration

-0.197

NaN30.2-2 mM Sodium aziderespiration

0.061

Nigericin50 uM Nigericinrespiration

-0.993

TRC10-150 ug/mL Triclosanrespiration

-0.998

TRZ10-25 ug/mL Thioridazinerespiration

-2.214

Valinomycin0.5-10 uM Valinomycinrespiration

0.891

ZnSO42 mM ZnSO4respiration

0.101

menadione6-10 ug/mL Menadionerespiration

-0.188

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.429

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.243

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.189

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.611

NRP_1Non-replicating persistence stage 1dosRassociated

0.398

Amp0.2mg/mL AmpicillincellWall

0.473

Cephalexin20-100 ug/mL CephalexincellWall

0.681

Cerulenin0.32-5 ug/mL CerulenincellWall

0.243

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.271

EMB10-20 ug/mL EthambutolcellWall

0.473

Eta12-40 ug/mL EthionamidecellWall

0.547

INH0.2-0.4 ug/mL IsoniazidcellWall

0.138

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.264

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.676

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.494

BZA0.12 mg/mL BenzamidearomaticAmides

0.781

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.609

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.694

H2O24 mM hydrogen peroxideDNAdamaging

0.346

Levo10 ug/mL LevofloxacinDNAdamaging

0.706

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.251

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.033

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.972

UVUV-irradiationDNAdamaging

-0.669

ARP41-4 ug/mL Antitubercular compound ARP4?

0.682

Antimycin12.5-50 ug/mL Antimycin A?

0.210

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.397

PA_110-50 ug/mL Antitubercular compound PA-1?

0.486

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.090

PA8240.2-2 ug/mL PA-824?

-1.201

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.049

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.443

Verapamil50 uM Verapamil?

0.376

mercaptoethanol2 mM 2-Mercaptoethanol?

0.523

methoxatin10-20 ug/mL Methoxatin?